|
ZNF780A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.27530000004761E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.0120999994796E-07 |
| Normal-vs-Stage2 |
1.162030E-03 |
| Normal-vs-Stage3 |
3.10259999913853E-08 |
| Normal-vs-Stage4 |
2.44969999840805E-09 |
| Stage1-vs-Stage2 |
1.401370E-01 |
| Stage1-vs-Stage3 |
1.320770E-01 |
| Stage1-vs-Stage4 |
1.000400E-02 |
| Stage2-vs-Stage3 |
1.439950E-02 |
| Stage2-vs-Stage4 |
1.697540E-03 |
| Stage3-vs-Stage4 |
1.508620E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.63880000470363E-08 |
| Normal-vs-AfricanAmerican |
1.137200E-03 |
| Normal-vs-Asian |
1.00569999994526E-06 |
| Caucasian-vs-AfricanAmerican |
6.161600E-01 |
| Caucasian-vs-Asian |
6.455400E-01 |
| AfricanAmerican-vs-Asian |
8.431600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.05320000054476E-07 |
| Normal-vs-Female |
9.68740000439894E-08 |
| Male-vs-Female |
5.639200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.73410000026131E-07 |
| Normal-vs-Age(41-60Yrs) |
4.76209999988875E-07 |
| Normal-vs-Age(61-80Yrs) |
2.0586000004652E-07 |
| Normal-vs-Age(81-100Yrs) |
1.830460E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.686000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.431400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.958200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.551400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.049400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.095000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.220870E-04 |
| Classical-VS-Follicular |
5.880000E-02 |
| Classical-VS-Other |
6.075400E-01 |
| Classical-VS-Normal |
4.68870000047694E-07 |
| Tall-VS-Follicular |
1.65099999999141E-05 |
| Tall-VS-Other |
4.938400E-01 |
| Tall-VS-Normal |
1.20400023284617E-10 |
| Follicular-VS-Other |
3.273400E-01 |
| Follicular-VS-Normal |
1.009210E-04 |
| Other-VS-Normal |
1.821940E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.94849999996172E-06 |
| Normal-vs-N1 |
9.19260001452926E-10 |
| N0-vs-N1 |
4.176700E-04 |
|
|
